2-(1-Methoxycyclopropyl)acetic Acid - CAS 1546448-89-8
Catalog: |
BB060393 |
Product Name: |
2-(1-Methoxycyclopropyl)acetic Acid |
CAS: |
1546448-89-8 |
Synonyms: |
1-Methoxycyclopropaneacetic Acid |
IUPAC Name: | 2-(1-methoxycyclopropyl)acetic acid |
Description: | 2-(1-Methoxycyclopropyl)acetic Acid is a useful research chemical used in the preparation of substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors. |
Molecular Weight: | 130.14 |
Molecular Formula: | C6H10O3 |
Canonical SMILES: | COC1(CC1)CC(=O)O |
InChI: | InChI=1S/C6H10O3/c1-9-6(2-3-6)4-5(7)8/h2-4H2,1H3,(H,7,8) |
InChI Key: | NCPHNERIMKBGLV-UHFFFAOYSA-N |
References: | Andrews, S. W., et al. PCT Int. Appl. WO 2018071454, 946, (2018). |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
EA-037208-B1 | SUBSTITUTED PYRAZOLO [1,5-a] PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS | 20170929 |
AU-2017342027-A1 | Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors | 20161010 |
EP-3523302-A1 | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | 20161010 |
JP-2019533670-A | Substituted pyrazolo [1,5-A] pyridine compounds as RET kinase inhibitors | 20161010 |
KR-20190077389-A | Substituted pyrazolo [1,5-a] pyridine compounds as RET kinase inhibitors | 20161010 |
TW-201827428-A | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | 20161010 |
US-10144734-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | 20161010 |
US-10172845-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | 20161010 |
US-10441581-B2 | Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | 20161010 |
US-2018133207-A1 | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors | 20161010 |
Complexity: | 126 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 130.062994177 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 130.062994177 |
Rotatable Bond Count: | 3 |
Topological Polar Surface Area: | 46.5Ų |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -0.1 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Other Building Blocks
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS